TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy

Myotonic dystrophy type 1 (DM1), the most prevalent muscular dystrophy in adults, is characterized by progressive muscle wasting and multi-systemic complications. DM1 is the prototype for disorders caused by RNA toxicity. Currently, no therapies exist. Here, we identify that fibroblast growth factor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Mol Genet
Egile Nagusiak: Yadava, Ramesh S., Foff, Erin P., Yu, Qing, Gladman, Jordan T., Kim, Yun K., Bhatt, Kirti S., Thornton, Charles A., Zheng, Timothy S., Mahadevan, Mani S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4355029/
https://ncbi.nlm.nih.gov/pubmed/25504044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddu617
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak